32704090|t|Urolithin A suppresses high glucose-induced neuronal amyloidogenesis by modulating TGM2-dependent ER-mitochondria contacts and calcium homeostasis.
32704090|a|Hyperglycemia in diabetes mellitus (DM) patients is a causative factor for amyloidogenesis and induces neuropathological changes, such as impaired neuronal integrity, neurodegeneration, and cognitive impairment. Regulation of mitochondrial calcium influx from the endoplasmic reticulum (ER) is considered a promising strategy for the prevention of mitochondrial ROS (mtROS) accumulation that occurs in the Alzheimer's disease (AD)-associated pathogenesis in DM patients. Among the metabolites of ellagitannins that are produced in the gut microbiome, urolithin A has received an increasing amount of attention as a novel candidate with anti-oxidative and neuroprotective effects in AD. Here, we investigated the effect of urolithin A on high glucose-induced amyloidogenesis caused by mitochondrial calcium dysregulation and mtROS accumulation resulting in neuronal degeneration. We also identified the mechanism related to mitochondria-associated ER membrane (MAM) formation. We found that urolithin A-lowered mitochondrial calcium influx significantly alleviated high glucose-induced mtROS accumulation and expression of amyloid beta (Abeta)-producing enzymes, such as amyloid precursor protein (APP) and beta-secretase-1 (BACE1), as well as Abeta production. Urolithin A injections in a streptozotocin (STZ)-induced diabetic mouse model alleviated APP and BACE1 expressions, Tau phosphorylation, Abeta deposition, and cognitive impairment. In addition, high glucose stimulated MAM formation and transglutaminase type 2 (TGM2) expression. We first discovered that urolithin A significantly reduced high glucose-induced TGM2 expression. In addition, disruption of the AIP-AhR complex was involved in urolithin A-mediated suppression of high glucose-induced TGM2 expression. Markedly, TGM2 silencing inhibited inositol 1, 4, 5-trisphosphate receptor type 1 (IP3R1)-voltage-dependent anion-selective channel protein 1 (VDAC1) interactions and prevented high glucose-induced mitochondrial calcium influx and mtROS accumulation. We also found that urolithin A or TGM2 silencing prevented Abeta-induced mitochondrial calcium influx, mtROS accumulation, Tau phosphorylation, and cell death in neuronal cells. In conclusion, we suggest that urolithin A is a promising candidate for the development of therapies to prevent DM-associated AD pathogenesis by reducing TGM2-dependent MAM formation and maintaining mitochondrial calcium and ROS homeostasis.
32704090	0	11	Urolithin A	Chemical	MESH:C026423
32704090	28	35	glucose	Chemical	MESH:D005947
32704090	44	68	neuronal amyloidogenesis	Disease	MESH:D009410
32704090	83	87	TGM2	Gene	21817
32704090	127	134	calcium	Chemical	MESH:D002118
32704090	148	161	Hyperglycemia	Disease	MESH:D006943
32704090	165	182	diabetes mellitus	Disease	MESH:D003920
32704090	184	186	DM	Disease	MESH:D003920
32704090	188	196	patients	Species	9606
32704090	223	238	amyloidogenesis	Disease	
32704090	286	313	impaired neuronal integrity	Disease	MESH:D000081042
32704090	315	332	neurodegeneration	Disease	MESH:D019636
32704090	338	358	cognitive impairment	Disease	MESH:D003072
32704090	374	387	mitochondrial	Disease	MESH:D028361
32704090	388	395	calcium	Chemical	MESH:D002118
32704090	496	509	mitochondrial	Disease	MESH:D028361
32704090	510	513	ROS	Chemical	-
32704090	515	520	mtROS	Chemical	-
32704090	554	573	Alzheimer's disease	Disease	MESH:D000544
32704090	575	577	AD	Disease	MESH:D000544
32704090	606	608	DM	Disease	MESH:D003920
32704090	609	617	patients	Species	9606
32704090	644	657	ellagitannins	Chemical	MESH:D047348
32704090	699	710	urolithin A	Chemical	MESH:C026423
32704090	830	832	AD	Disease	MESH:D000544
32704090	890	897	glucose	Chemical	MESH:D005947
32704090	906	921	amyloidogenesis	Disease	
32704090	932	945	mitochondrial	Disease	MESH:D028361
32704090	946	967	calcium dysregulation	Disease	MESH:D002128
32704090	972	977	mtROS	Chemical	-
32704090	1004	1025	neuronal degeneration	Disease	MESH:D009410
32704090	1071	1094	mitochondria-associated	Disease	MESH:C564971
32704090	1138	1149	urolithin A	Chemical	MESH:C026423
32704090	1158	1171	mitochondrial	Disease	MESH:D028361
32704090	1172	1179	calcium	Chemical	MESH:D002118
32704090	1217	1224	glucose	Chemical	MESH:D005947
32704090	1233	1238	mtROS	Chemical	-
32704090	1284	1289	Abeta	Gene	11820
32704090	1318	1343	amyloid precursor protein	Gene	11820
32704090	1354	1370	beta-secretase-1	Gene	23821
32704090	1372	1377	BACE1	Gene	23821
32704090	1391	1396	Abeta	Gene	11820
32704090	1409	1420	Urolithin A	Chemical	MESH:C026423
32704090	1437	1451	streptozotocin	Chemical	MESH:D013311
32704090	1453	1456	STZ	Chemical	MESH:D013311
32704090	1466	1474	diabetic	Disease	MESH:D003920
32704090	1475	1480	mouse	Species	10090
32704090	1506	1511	BACE1	Gene	23821
32704090	1546	1551	Abeta	Gene	11820
32704090	1568	1588	cognitive impairment	Disease	MESH:D003072
32704090	1608	1615	glucose	Chemical	MESH:D005947
32704090	1645	1668	transglutaminase type 2	Gene	21817
32704090	1670	1674	TGM2	Gene	21817
32704090	1713	1724	urolithin A	Chemical	MESH:C026423
32704090	1752	1759	glucose	Chemical	MESH:D005947
32704090	1768	1772	TGM2	Gene	21817
32704090	1816	1819	AIP	Gene	11632
32704090	1820	1823	AhR	Gene	11622
32704090	1848	1859	urolithin A	Chemical	MESH:C026423
32704090	1889	1896	glucose	Chemical	MESH:D005947
32704090	1905	1909	TGM2	Gene	7052
32704090	1932	1936	TGM2	Gene	7052
32704090	1957	2003	inositol 1, 4, 5-trisphosphate receptor type 1	Gene	3708
32704090	2005	2010	IP3R1	Gene	3708
32704090	2012	2063	voltage-dependent anion-selective channel protein 1	Gene	7416
32704090	2065	2070	VDAC1	Gene	7416
32704090	2104	2111	glucose	Chemical	MESH:D005947
32704090	2120	2133	mitochondrial	Disease	MESH:D028361
32704090	2134	2141	calcium	Chemical	MESH:D002118
32704090	2153	2158	mtROS	Chemical	-
32704090	2192	2203	urolithin A	Chemical	MESH:C026423
32704090	2207	2211	TGM2	Gene	21817
32704090	2232	2237	Abeta	Gene	11820
32704090	2246	2259	mitochondrial	Disease	MESH:D028361
32704090	2260	2267	calcium	Chemical	MESH:D002118
32704090	2276	2281	mtROS	Chemical	-
32704090	2463	2465	DM	Disease	MESH:D003920
32704090	2477	2479	AD	Disease	MESH:D000544
32704090	2505	2509	TGM2	Gene	7052
32704090	2550	2563	mitochondrial	Disease	MESH:D028361
32704090	2564	2571	calcium	Chemical	MESH:D002118
32704090	2576	2579	ROS	Chemical	-
32704090	Negative_Correlation	MESH:C026423	MESH:D000544
32704090	Association	11622	7052
32704090	Association	MESH:D002118	7052
32704090	Association	7052	7416
32704090	Association	MESH:D028361	11820
32704090	Negative_Correlation	MESH:C026423	MESH:D002118
32704090	Association	MESH:D002118	11820
32704090	Negative_Correlation	MESH:C026423	MESH:D003072
32704090	Association	MESH:D005947	MESH:D028361
32704090	Negative_Correlation	MESH:C026423	7052
32704090	Association	MESH:D028361	7052
32704090	Association	MESH:D028361	23821
32704090	Association	MESH:D009410	11820
32704090	Association	MESH:C026423	11622
32704090	Positive_Correlation	MESH:D005947	MESH:D009410
32704090	Negative_Correlation	MESH:C026423	MESH:D028361
32704090	Association	MESH:D002118	MESH:D005947
32704090	Positive_Correlation	MESH:D005947	7052
32704090	Association	MESH:C026423	11632
32704090	Negative_Correlation	MESH:C026423	MESH:D005947
32704090	Negative_Correlation	MESH:C026423	11820
32704090	Negative_Correlation	MESH:C026423	21817
32704090	Association	11820	23821
32704090	Association	11622	11632
32704090	Association	MESH:D002118	MESH:D028361
32704090	Negative_Correlation	MESH:C026423	MESH:D009410
32704090	Positive_Correlation	MESH:D013311	MESH:D003920
32704090	Positive_Correlation	MESH:D005947	11820
32704090	Association	MESH:D009410	21817
32704090	Association	MESH:D002118	MESH:D000544
32704090	Association	3708	7052
32704090	Positive_Correlation	MESH:D005947	23821
32704090	Association	11632	7052
32704090	Positive_Correlation	MESH:D005947	21817
32704090	Association	MESH:D002118	23821
32704090	Negative_Correlation	MESH:C026423	23821

